Search Login Register

No-Reflow Phenomenon Summary

Description: Markedly reduced or absent REPERFUSION in an infarct zone following the removal of an obstruction or constriction of an artery.

Also Known As: Slow-Flow Phenomenon; No Reflow Phenomenon; Phenomenon, Slow-Flow; Slow Flow Phenomenon

Networked: 370 relevant articles (21 outcomes, 51 trials/studies) for this Disease

Key Drugs and Agents for No-Reflow Phenomenon

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Verapamil (Calan) : 4 outcomes 3 studies in 12 results : FDA 64 Generic
  2. Urokinase-Type Plasminogen Activator (Urokinase) : 3 outcomes in 4 results : FDA 2
  3. Adenosine : 2 outcomes 4 studies in 24 results : FDA 19 Generic
  4. Nitroprusside (Sodium Nitroprusside) : 2 outcomes 2 studies in 13 results : FDA 8 Generic
  5. Oxygen : 1 outcome 2 studies in 12 results : IBA
  6. Nitric Oxide (Nitrogen Monoxide) : 1 outcome 1 study in 4 results : FDA 1
  7. Adenosine Triphosphate (ATP) : 1 outcome 1 study in 2 results : IBA
  8. eptifibatide (Integrilin) : 1 outcome 1 study in 2 results : FDA 1
  9. yiki-huoxue : 1 outcome 1 study in 1 result : IBA
  10. abciximab (ReoPro) : 1 outcome in 6 results : FDA 2
Show All >>

Diseases Related to No-Reflow Phenomenon

  1. Thrombosis (Thrombus)
  2. Myocardial Infarction
  3. Ischemia
  4. Hypercholesterolemia
  5. Coronary Artery Disease (Coronary Atherosclerosis)
Show All >>

Key Therapies for No-Reflow Phenomenon

Efficacy Chart >>
  1. Transplants (Transplant) : 2 outcomes 1 study in 24 results
  2. Angioplasty (Angioplasty, Transluminal) : 1 outcome 3 studies in 36 results
  3. Coronary Atherectomy : 1 outcome 2 studies in 9 results
  4. Stents : 1 outcome 1 study in 31 results
  5. Replantation : 1 outcome 1 study in 7 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.